previous compound ID: 35 next compound
InChIKey: FTVWIRXFELQLPI-UHFFFAOYSA-N
SMILES: C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O

biological descriptors:

CFTR relevance: ΔF508 CFTR activation

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 41
"K Backer" "JP Clancy" "JC Fulton" "M Mazur" "LC Pyle" "S Barnes" "SM Rowe" "J Prasain" "PA Sloane"
ReferenceID: 53
"DY Thomas" "B Kus" "J Liao" "SD Macknight" "D Rotin" "R Robert" "E Matthes" "GW Carlile" "J Goepp" "JW Hanrahan"

chemical graph of compound 35




CID is 932
synonyms found at PubChem are:
naringenin, 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, 67604-48-2, 4',5,7-Trihydroxyflavanone, Naringenine, (+/-)-Naringenin, 480-41-1, naringetol, salipurpol, (-)-Naringenin, NARIGENIN, Salipurol, 93602-28-9, 5,7,4'-Trihydroxyflavanone, (S)-Naringenin, NSC 34875, ( inverted exclamation markA)-Naringenin, CHEMBL32571, MLS000028739, MLS000738094, CHEBI:50202, Flavanone, 4',5,7-trihydroxy-, FTVWIRXFELQLPI-UHFFFAOYSA-N, NSC11855, NSC34875, SMR000059039, 4',7-Trihydroxyflavanone, NSC 11855, Flavanone,5,7-trihydroxy-, Q-100521, EINECS 207-550-2, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one, pelargidanon 1602, 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (S)-, naringenin-7-sulfate, NSC-34875, Narngenn, rac Naringenin, CCRIS 8135, (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone, NSC-11855, 4H-1-Benzopyran-4-one,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (S)-, Naringenin (NAR), Prestwick_531, EINECS 266-769-1, Naringenin, 90%, (R,S)-Naringenin, BE 14348A, BE-14348A, Opera_ID_106, AC1L1ACN, AC1Q6KJD, Prestwick0_000466, Prestwick1_000466, Prestwick2_000466, Prestwick3_000466, Oprea1_194140, SCHEMBL20571, 4 ,5,7-Trihydroxyflavanone, BSPBio_000572, MLS001146907, SPBio_002511, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one, BPBio1_000630, MEGxp0_000358, SCHEMBL1934259, ACon1_000582, BDBM19461, CTK7J9188, DTXSID50274239, MolPort-000-861-091, (+/-)-Naringenin, >=95%, HMS1569M14, HMS2096M14, HMS2231O18, HMS3352B08, HMS3373N07, HMS3656G15, Naringenin, natural (US), 98%, KS-000001ZW, ZX-AT026530, ANW-43843, BN0800, CN0031, SBB006461, Naringenin solution, 20 mM in DMSO, (+/-)-5,7,4'-Trihydroxyflavanone, 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, AKOS015895052, (+/-)-Naringenin, analytical standard, CS-W012357, KS-5142, LS-5089, MCULE-5489217450, RL05877, (+/-)-Naringenin, ~95% (HPCE), KS-00000R53, SMP1_000060, NCGC00017346-02, NCGC00017346-03, NCGC00017346-04, NCGC00095963-01, NCGC00095963-02, NCGC00095963-03, 4CN-0924, AC-20273, AK122638, AN-45184, K702, LS-39547, SC-18078, ST057236, AB1003941, AB1009825, AX8246816, KB-187979, KB-196356, ST2418556, TR-017609, TR-037462, 4CH-012369, FT-0082287, FT-0630981, N0072, M-7677, Naringenin, disposable screening library format, S00279, 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chroman-4-one, I06-0445, I06-0536, J-523457, 4',5,7-Trihydroxyflavanone solution, 20 mM in DMSO, BRD-A94669766-001-02-6, BRD-A94669766-001-04-2, 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one, EC19096C-4404-4A16-9BF9-92F9F358E005, ( )-Naringenin; 4?,5,7-Trihydroxyflavanone; H-1-benzopyran-4-one, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one, (S)- #, ( inverted exclamation markA)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 4 inverted exclamation marka,5,7-Trihydroxyflavanone